Health Condition 1: I824- Acute embolism and thrombosis of deep veins of lower extremity Health Condition 2: null- Thromboembolism prophylaxis in oncology patients who are undergoing abdominal or pelvic surgery
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female patient >= 18 years of age 2. Patients hospitalized for surgery of abdominal or pelvic (such as colon, rectum, stomach, liver, pancreas, prostate, urinary bladder, uterus and ovarian) malignant tumor 3. Patients who have undergone surgery for this malignant tumor in the last 2 days 4. Signed Informed consent
Exclusion criteria
Exclusion criteria: 1.Patient with a life expectancy of less than 1 month 2.Patient currently participating in a clinical trial
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1. Proportion of patients who develop symptomatic DVT at the end of 30 days 2. To evaluate the profile of patients who are admitted (in terms of: Age, gender, type of malignant tumor, stage of malignancy, type of admitting hospital). The profile of the patients will be analyzed for thromboprophylaxis given or not and if the patient develops symptomatic DVT or not. 3. Reasons for not administering thromboprophylaxis Timepoint: 30 days | — |
Primary
| Measure | Time frame |
|---|---|
| Proportion of oncology patient undergoing surgery for the malignant abdominal or pelvic tumor who are given thromboprophylaixs Timepoint: not applicable | — |
Countries
India
Contacts
Sanofi